Pfizer and biontech receive positive chmp opinion for omicron ba.1-adapted bivalent covid-19 vaccine booster in european union

New york & mainz, germany--(business wire)--pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced a 30-Μg booster dose of their omicron ba.1 bivalent covid-19 vaccine (comirnaty® original/omicron ba.1 15/15 Μg) has been recommended for conditional marketing authorization (cma) by the european medicines agency's (ema) committee for medicinal products for human use (chmp) for individuals 12 years and older. the european commission will review the chmp recommendation and is expect
BNTX Ratings Summary
BNTX Quant Ranking